Bone Biologics (BBLG) Metrics: History & Chart

Bone Biologics Corporation(BBLG)

Biotechnology · Burlington, MA

$0.48-0.01 (-1.17%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Bone Biologics Corporation

Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.

Burlington, MA

2 employees

www.bonebiologics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jeffrey Frelick

View full financials

Third-Party DCF Estimate (FMP)	$4.22
Price Gap vs Third-Party Estimate	+769.15%

7D Total Return	-2.24%
30D Total Return	-14.64%
YTD Total Return	-66.54%
1Y Total Return	-80.59%
3Y Total Return	-98.23%
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-66.54%
2025	-74.29%
2024	-79.20%
2023	-82.06%
2022	-94.04%
2021	N/A
2020

CAGR TTM	-80.44%
CAGR 3Y	-73.93%
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	0.00
PE Ratio Avg TTM	0.00
PE Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

BBLG Valuation Metrics

BBLG Stock Price Metrics

BBLG Dividend Metrics

BBLG Growth Rate Metrics

BBLG Discounted Cash Flow Metrics

BBLG Returns By Period

BBLG Yearly Returns

BBLG Average Annual Returns By Period (CAGR)

BBLG Revenue Metrics

BBLG PE Ratio Metrics

BBLG PS Ratio Metrics

BBLG PB Ratio Metrics

BBLG Price to Free Cash Flow Ratio Metrics

BBLG Debt to Equity Ratio Metrics

BBLG PEG Ratio Metrics

BBLG FCF Yield

BBLG Earnings Yield

BBLG EBITDA Yield

BBLG OCF Yield

BBLG EV/EBIT Ratio Metrics

BBLG EV/EBITDA Ratio Metrics

BBLG EV/Assets Ratio Metrics

BBLG EV/Sales Ratio Metrics

BBLG Current Ratio Metrics

BBLG Quick Ratio Metrics

BBLG ROIC Metrics

BBLG Return on Assets Metrics

BBLG Return on Equity Metrics

BBLG Net Profit Margin Metrics

BBLG Gross Profit Margin Metrics

BBLG Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	0.22
PB Ratio Avg TTM	0.36
PB Ratio Avg 3Y	1.94
Current VS TTM Avg	-39.45%
Current VS 3Y Avg	-88.68%
Current VS 5Y Avg	-90.06%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	60423749.68%
Earnings Yield Avg TTM	30990441.81%
Earnings Yield Avg 3Y	30990441.81%
Current VS TTM Avg	+94.98%
Current VS 3Y Avg	+94.98%
Current VS 5Y Avg	+94.98%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.50
Ev/Assets Ratio Avg TTM	2.54
Ev/Assets Ratio Avg 3Y	1.43
Current VS TTM Avg	-40.99%
Current VS 3Y Avg	+4.64%
Current VS 5Y Avg	-34.33%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	8.67
Current Ratio Avg TTM	14.97
Current Ratio Avg 3Y	12.29
Current VS TTM Avg	-42.11%
Current VS 3Y Avg	-29.48%
Current VS 5Y Avg	-8.93%

Quick Ratio	8.67
Quick Ratio Avg TTM	14.97
Quick Ratio Avg 3Y	12.47
Current VS TTM Avg	-42.11%
Current VS 3Y Avg	-30.52%
Current VS 5Y Avg	-10.18%

ROIC	(78.01%)
ROIC Avg 3Y	(138.57%)
ROIC Avg 5Y	(105.58%)
Current VS 3Y Avg	+43.71%
Current VS 5Y Avg	+26.12%
Current VS 10Y Avg	+34.50%

ROA	(65.16%)
ROA Avg TTM	(13.14%)
ROA Avg 3Y	(23.91%)
Current VS TTM Avg	-395.83%
Current VS 3Y Avg	-172.57%
Current VS 5Y Avg	-209.00%

ROE	(73.66%)
ROE Avg TTM	(64.45%)
ROE Avg 3Y	(124.57%)
Current VS TTM Avg	-14.29%
Current VS 3Y Avg	+40.87%
Current VS 5Y Avg	+19.42%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	(0.18%)
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	-1515.19%